Preeclampsia is a disease associated with hypertension during pregnancy. It can lead to serious complications, both in the mother and in the foetus, and is only resolved with the birth.
Which patients is it most useful for?
Pregnant women with a risk factor that could trigger preeclampsia:
It can appear early (<34 weeks of gestation) due to abnormal placental implantation or late (> 34 weeks), presenting fewer risks in the maternal-foetal prognosis.
What does it analyse?
At Laboratorio Echevarne we present a test capable of the early diagnosis of preeclampsia through a blood test. This test uses levels of two angiogenic markers, sFlt1 and PIGF, which makes it possible to identify women who will develop preeclampsia, as their PIGF levels are lower than in normal pregnancies and those of sFlt1 are higher and increase earlier.
|PIGF: Pro-angiogenic factor that stimulates the formation of blood vessels in the placenta|
|sFlt1: Anti-angiogenic factor. Vascular endothelial growth factor receptor|
|The sFlt-1/PlGF ratio makes it possible to diagnose pre-eclampsia before clinical symptoms arrive|